Skip to main content
. 2016 Apr 12;7(19):28612–28623. doi: 10.18632/oncotarget.8704

Table 1. Comparison of the accuracy of predictions using different in vivo data.

Drug Group Within a 2-fold error Outside a 2-fold error χ2 P-value
Number Percentage Number Percentage
Omeprazole Control 55 53.92 47 46.08 0.480
HCC 60 58.82 42 41.18
Midazolam Control 95 93.14 7 6.86 1.000
HCC 95 93.14 7 6.86

Control: using a correction coefficient that applies to patients with normal liver function. HCC: using a correction coefficient calculated based on in vivo clearance in patients with cirrhosis.